media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Solara Active Pharma Sciences Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121214
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]1379.191230.551575.731267.641322.08
Other Operating Revenues64.6237.7941.1554.1164.59
Total Operating Revenues1443.811268.341616.881321.751386.68
      
Other Income22.5520.0228.7727.5212.38
Total Revenue1466.361288.361645.651349.271399.06
      
EXPENSES     
Cost Of Materials Consumed773.90858.86683.77623.36729.54
Purchase Of Stock-In Trade7.8853.7842.8029.679.08
Changes In Inventories Of FG,WIP And Stock-In Trade7.05-258.75-2.15-54.16-33.79
Employee Benefit Expenses228.63236.34229.37204.13185.81
Finance Costs90.0675.2884.4877.8982.42
Depreciation And Amortisation Expenses111.19112.32108.6694.1683.09
Other Expenses292.47298.14277.22259.31275.23
Total Expenses1511.181375.971424.151234.361331.37
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-44.82-87.61221.50114.9167.69
      
Exceptional Items0.00-3.490.000.000.00
Profit/Loss Before Tax-44.82-91.10221.50114.9167.69
      
Tax Expenses-Continued Operations     
Current Tax-0.090.1738.8021.2215.97
Deferred Tax-22.48-32.98-38.65-20.69-13.95
Tax For Earlier Years0.000.000.00-0.14-1.43
Total Tax Expenses-22.57-32.810.150.390.59
Profit/Loss After Tax And Before ExtraOrdinary Items-22.25-58.29221.35114.5267.10
      
Profit/Loss From Continuing Operations-22.25-58.29221.35114.5267.10
      
Profit/Loss From Discontinuing Operations0.000.000.000.00-9.92
Total Tax Expenses Discontinuing Operations0.000.000.000.00-2.24
Net Profit/Loss From Discontinuing Operations0.000.000.000.00-7.68
Profit/Loss For The Period-22.25-58.29221.35114.5259.43
      
Minority Interest0.070.140.050.090.10
Consolidated Profit/Loss After MI And Associates-22.18-58.15221.40114.6159.53
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-6.16-16.1869.0044.2921.77
Diluted EPS (Rs.)-6.16-16.1864.5342.8221.73
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.0010.7819.7215.630.00
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]1379.19
Other Operating Revenues64.62
Total Operating Revenues1443.81
Other Income22.55
Total Revenue1466.36
EXPENSES 
Cost Of Materials Consumed773.90
Purchase Of Stock-In Trade7.88
Changes In Inventories Of FG,WIP And Stock-In Trade7.05
Employee Benefit Expenses228.63
Finance Costs90.06
Depreciation And Amortisation Expenses111.19
Other Expenses292.47
Total Expenses1511.18
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-44.82
Exceptional Items0.00
Profit/Loss Before Tax-44.82
Tax Expenses-Continued Operations 
Current Tax-0.09
Deferred Tax-22.48
Tax For Earlier Years0.00
Total Tax Expenses-22.57
Profit/Loss After Tax And Before ExtraOrdinary Items-22.25
Profit/Loss From Continuing Operations-22.25
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period-22.25
Minority Interest0.07
Consolidated Profit/Loss After MI And Associates-22.18
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-6.16
Diluted EPS (Rs.)-6.16
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00